HIGHLIGHTS
- who: Romeo Romagnoli and collaborators from the Department of Chemical, Pharmaceutical and Agricultural Sciences, University of Ferrara, Ferrara, Italy have published the research: Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities, in the Journal: Pharmaceuticals 2022, 15, x FOR PEER REVIEW of /2022/
- what: The clinical success of these three classes of compounds has stimulated intensive research aimed at discovering additional microtubule-targeting drugs with clinical potential . Once the 7-(30,40,50 -trimethoxyphenyl)-[1,2,4]triazol pyrimidine motif was identified as the minimum structural requirement . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.